Solid Biosciences SLDB 深 滬
等待開盤 09-20 09:30:00 美东时间
8.00
+0.860
+12.04%
華盛通- 最 高8.10
- 今 開7.42
- 成交量 20.57万股
- 最 低 7.22
- 昨 收 7.14
- 總市值 1.60亿
- 52周最高 15.05
- 市盈率 靜 --
- 換手率 1.03%
- 52周最低 1.81
- 委 比 -49.55%
- 總股本 2006.00万
- 歷史最高 822.60
- 量 比 0.66
- 振 幅 12.32%
- 歷史最低 1.81
- 每 手 1
- 風險率 3.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around...
09-16 20:44
Dyne stock tumbles 31% amid drug updates, management changes
Shares of Dyne Therapeutics (NASDAQ:DYN) fell 31% Tuesday after the company released new data from a clinical trial called DELIVER for its drug DYNE-251 in the treatment of Duchenne muscular dystrophy...
09-04 04:48
快讯 | Solid Biosciences Inc：Chardan资本市场将目标价从6美元上调至15美元。
Solid Biosciences Inc : Chardan Capital Markets Raises Target Price to $15 From...
08-19 13:14
Solid Biosciences Q2 EPS $(0.61) Beats $(0.67) Estimate
Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.67) by 8.96 percent. This is a 51.2 percent increase over losses of $(1.25) per share from
08-14 04:56
快讯 | Solid Biosciences Inc：预计现金储备能维持到2026年。
Solid Biosciences Inc: Anticipated Cash Runway Into 2026
08-14 04:18
快讯 | solid biosciences第二季度净利润美元指数-2510万
Solid Biosciences Q2 Net Income USD -25.1 Million
08-14 04:08
快讯 | Solid biosciences报告2024年第二季度财务业绩并提供业务更新。
Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Bu...
08-14 04:08
PepGen stock tumbles 25% following release of DMD drug data
PepGen (NASDAQ:PEPG) stock plunged 25% in post-market trading Tuesday after the company released data for its drug PGN-EDO51 in the treatment of Duchenne muscular dystrophy, or DMD. PepGen reported da...
07-31 07:37
Solid Biosciences’ SGT-003: A Promising Leap in DMD Therapy with Cardiac Safety Superiority
Analyst David Hoang from Citi maintained a Buy rating on Solid Biosciences (SLD...
07-18 08:36
快讯 | Solid Biosciences Inc: Leerink Partners将目标价从12美元提高至28美元。
Solid Biosciences Inc : Leerink Partners Raises Target Price to $28 From $12
07-16 11:04
